STAT3 and glioblastoma: Our findings are consistent with a previous study demonstrating that targeting STAT3 leads to the downregulation of the expression of the STAT3 protein, promotes the degradation of STAT3 ubiquitination, and inhibits cell metastasis in human glioblastoma cells [13].